The DEA clarifies hexahydrocannabinol (HHC) is a federally illegal Schedule I substance, assigning it a new drug code. This ...

The U.S. House passed the Farm Bill, leaving federal rules for hemp-derived cannabinoids unchanged. Learn how this impacts ...

A new poll reveals 75% of Texas voters support medical cannabis reforms, despite low awareness of the state's Compassionate ...

Explore how potential US federal medical cannabis reclassification could impact market dynamics, regulatory frameworks, and ...

The US Department of Justice's move to reclassify medical cannabis to Schedule III could unlock critical research ...

Virginia's adult-use cannabis market faces continued uncertainty after lawmakers rejected Governor Spanberger's extensive ...

Explore how federal cannabis rescheduling could activate existing South Carolina laws, potentially granting patients medical ...

Texas industrial hemp businesses are challenging state regulations banning smokable products and increasing licensing fees.

New Zealand's medicinal cannabis prescriptions surged to 44% of users in 2025, driven by clinics and online access. Explore ...

Maryland's new law, effective October 1, protects firefighters and EMTs using medical cannabis off-duty. Learn how this ...

Discover how smarter, real-time clinical trials could reshape drug development, offering more efficient pathways for new ...

Florida regulators have cited multi-state operator Trulieve for alleged environmental violations at a cannabis cultivation ...